Currently working as a Global Health Economist at the department "Global Pricing and Market Access"鈥� in Roche headquarters (Basel, Switzerland).
My understanding of HTA and payer environment allows me to lead complex projects to inform HTA/payer submissions around the world.
I am responsible for developing the scientific evidence needed to establish the economic value of Roche drugs. This information is used to:
1) Optimize the drug development program
2) Define the economic value messages that support the Market Access strategy
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
